4//SEC Filing
Khan Najat 4
Accession 0002020969-25-000006
CIK 0001601830other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 7:37 PM ET
Size
4.9 KB
Accession
0002020969-25-000006
Insider Transaction Report
Form 4
Khan Najat
DirectorChief R&D Commercial Officer
Transactions
- Tax Payment
Class A Common Stock
2025-11-17$4.14/sh−17,584$72,798→ 735,538 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0002020969
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 7:37 PM ET
- Size
- 4.9 KB